April 2, 2020 AlzeCure Pharma today presented key preclinical data on its novel cognitive enhancer at the AAT-AD/PD conference
March 16, 2020 AlzeCure Pharma to present late breaking abstract at the AAT-AD/PD conference (Advances in Alzheimer’s and Parkinson’s Therapies)
March 3, 2020 An van Es-Johansson joins management team at AlzeCure Pharma – resigns from Board of Directors
January 7, 2020 AlzeCure Pharma Conducts Strategic Inlicensing of Clinical Phase Drug Candidate for Neuropathic Pain
